-+ 0.00%
-+ 0.00%
-+ 0.00%

Akebia Therapeutics Repays $55 Million Loan in Full

PUBT·11/16/2026 13:09:18
Listen to the news
Akebia Therapeutics Repays $55 Million Loan in Full
  • Akebia Therapeutics repaid its $55 million BlackRock loan facility in full using proceeds from Symbiotic Capital's initial $60 million tranche.
  • The senior secured term loan facility, worth up to $140 million, closed on November 12, 2026.
  • An additional tranche of up to $80 million is available at Symbiotic Capital's discretion.
  • The facility has a 60-month maturity with interest-only payments throughout; principal is due at maturity.
  • The variable monthly interest rate equals the greater of WSJ Prime plus 4.5% or 11.5%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akebia Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611160800PRIMZONEFULLFEED9878004) on November 16, 2026, and is solely responsible for the information contained therein.